Eraxis (anidulafungin) for serious Candida fungal infections
June 2006
Pfizer will be promoting Eraxis (anidulafungin) for serious Candida fungal infections.
It's similar to Cancidas (caspofungin) and Mycamine (micafungin). These "candins" inhibit formation of the fungal cell wall.
Eraxis is given IV. It will be used for Candida infections in the bloodstream. It's more effective than fluconazole.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote